CNO Financial Group Reports Second Quarter 2026 Results
CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. News For Immediate Release CNO Financial Group Reports Second Quarter 2026 Results Carmel, Ind., July 30, 2026 - CNO Financial Group, Inc. (NYSE: CNO) today reported its second quarter 2026 financial results: • Strong execution and momentum continues; Raising 2026 operating earni
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
This disclosure updates CNO’s quarterly financial trajectory, including net income, insurance product margins, investment income and losses, and balance sheet composition (investments, liabilities, equity). Traders can use it to reassess earnings power and investment-related volatility assumptions.
Market read
Provides fresh quarterly financial statement detail that may influence near-term positioning, but the excerpt does not show a standalone guidance change or major corporate event.
What to watch
Traders may instead focus on the direction of net realized investment losses, embedded derivative and market risk benefit fair value changes, and changes in deferred acquisition costs or reinsurance receivables.
2Q 2026 total revenues were $ 1,285.2 million and net income was $ 125.9 million, while net operating income was $ 119.5 million.
Total revenues, net income, net operating income, insurance product margin, and each reported annuity, health, and life margin were higher than their respective 1Q 2026 and 2Q 2025 tabulated amounts.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Insurance policy incomeGAAP | $680.7M | – | – |
| Net investment income: General account assetsGAAP | $411.9M | – | – |
| Net investment income: Policyholder and other special-purpose portfoliosGAAP | $185.1M | – | – |
| Realized investment lossesGAAP | −$8.6M | – | – |
| Other investment lossesGAAP | −$6.1M | – | – |
| Total investment lossesGAAP | −$14.7M | – | – |
| Fee revenue and other incomeGAAP | $22.2M | – | – |
| Total revenuesGAAP | $1.29B | – | – |
| Insurance policy benefitsGAAP | $742.5M | – | – |
| Liability for future policy benefits remeasurement gainGAAP | −$15.3M | – | – |
| Change in fair value of market risk benefitsGAAP | −$8.3M | – | – |
| Interest expenseGAAP | $55.3M | – | – |
| Amortization of deferred acquisition costs and present value of future profitsGAAP | $74.9M | – | – |
| Other operating costs and expensesGAAP | $276.4M | – | – |
| Total benefits and expensesGAAP | $1.13B | – | – |
| Income before income taxesGAAP | $159.7M | – | – |
| Income tax expenseGAAP | $33.8M | – | – |
| Net incomeGAAP | $125.9M | – | – |
| Net income per diluted shareGAAP | $ 1.33 | – | – |
| Total insurance product marginother | $279M | – | – |
| Income from insurance productsother | $126.1M | – | – |
| Operating earnings before taxesother | $151M | – | – |
| Net operating incomenon-GAAP | $119.5M | – | – |
| Net operating income per diluted sharenon-GAAP | $ 1.26 | – | – |
| Net non-operating incomeother | $6.4M | – | – |
| Net non-operating income per diluted shareother | $ 0.07 | – | – |
| Book value per common shareother | $ 27.96 | – | – |
| Book value per common share, excluding accumulated other comprehensive lossother | $ 40.72 | – | – |
| Book value per diluted share, excluding accumulated other comprehensive lossother | $ 39.92 | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| AnnuityInsurance policy income was $ 10.2 million, net investment income was $ 163.9 million, interest credited was $ (75.7) million, and annuity margin was $ 60.6 million. | $10.2M | – | – |
| HealthInsurance policy income was $ 436.4 million, net investment income was $ 75.8 million, insurance policy benefits were $ (322.3) million, and health margin was $ 147.2 million. | $436.4M | – | – |
| LifeInsurance policy income was $ 234.1 million, net investment income was $ 38.4 million, insurance policy benefits were $ (139.3) million, and life margin was $ 71.2 million. | $234.1M | – | – |
What drove it
- Total insurance product margin was $ 279.0 million, comprising annuity margin of $ 60.6 million, health margin of $ 147.2 million, and life margin of $ 71.2 million.
- Policyholder and other special-purpose portfolios net investment income was $ 185.1 million.
- General account assets net investment income was $ 411.9 million.
- Net non-operating income was $ 6.4 million, including $ 34.6 million of changes in fair value of embedded derivative liabilities and market risk benefits.
Concerns
- Insurance policy benefits were $ 742.5 million, compared with $ 576.6 million in 1Q 2026 and $ 658.4 million in 2Q 2025.
- Fee revenue and other income was $ 22.2 million, compared with $ 48.8 million in 1Q 2026 and $ 34.9 million in 2Q 2025.
- Expenses related to TechMod initiative were $ (9.7) million.
- Realized investment losses were $ (8.6) million and other investment losses were $ (6.1) million.
What to watch
- Health margin was $ 147.2 million and insurance policy benefits in Health were $ (322.3) million.
- Policyholder account balances were $ 19,640.9 million at Jun-26.
- Fixed indexed annuities average net insurance liabilities were $ 11,316.3 million and margin/average net insurance liabilities was 1.74 %.
- Investment borrowings were $ 2,941.7 million at Jun-26.
Balance sheet and cash flow
- Total investments were $ 30,742.9 million at Jun-26.
- Cash and cash equivalents - unrestricted were $ 1,289.7 million at Jun-26.
- Total assets were $ 39,861.2 million at Jun-26.
- Investment borrowings were $ 2,941.7 million at Jun-26.
- Borrowings related to variable interest entities were $ 274.5 million at Jun-26.
- Notes payable - direct corporate obligations were $ 1,336.3 million at Jun-26.
- Total liabilities were $ 37,269.6 million at Jun-26.
- Total shareholders' equity was $ 2,591.6 million at Jun-26.
Analysis
CNO reported 2Q 2026 total revenues of $ 1,285.2 million, compared with $ 1,029.6 million in 1Q 2026 and $ 1,151.5 million in 2Q 2025. Net income was $ 125.9 million and net income per diluted share was $ 1.33, versus $ 37.7 million and $ 0.39 in 1Q 2026 and $ 91.8 million and $ 0.91 in 2Q 2025. Net operating income was $ 119.5 million, or $ 1.26 per diluted share, compared with $ 101.3 million, or $ 1.05 per diluted share, in 1Q 2026.
Insurance product margin was $ 279.0 million, compared with $ 256.9 million in 1Q 2026 and $ 252.4 million in 2Q 2025. Health margin was $ 147.2 million, life margin was $ 71.2 million, and annuity margin was $ 60.6 million. Health insurance policy income was $ 436.4 million and health insurance policy benefits were $ (322.3) million. Life insurance policy income was $ 234.1 million, while annuity net investment income was $ 163.9 million.
The revenue mix included $ 411.9 million of general account assets net investment income and $ 185.1 million of policyholder and other special-purpose portfolios net investment income. Fee revenue and other income was $ 22.2 million. Benefits and expenses totaled $ 1,125.5 million, including $ 742.5 million of insurance policy benefits, $ 74.9 million of amortization of deferred acquisition costs and present value of future profits, and $ 276.4 million of other operating costs and expenses.
Non-operating items moved to net non-operating income of $ 6.4 million from net non-operating loss of $ (63.6) million in 1Q 2026. The 2Q 2026 figure included $ 34.6 million of changes in fair value of embedded derivative liabilities and market risk benefits, partially offset by $ (13.6) million of net realized investment losses from disposals, impairments and change in allowance for credit losses and $ (9.7) million of expenses related to TechMod initiative.
At Jun-26, total investments were $ 30,742.9 million, unrestricted cash and cash equivalents were $ 1,289.7 million, and total shareholders' equity was $ 2,591.6 million. Investment borrowings were $ 2,941.7 million and notes payable - direct corporate obligations were $ 1,336.3 million. The supplied filing text contains no forward guidance or capital-return disclosure.
Not in the filing
stated, not guessed- Forward guidance
- Prior-release outlook and guidance comparison
- Gross margin
- Operating cash flow
- Free cash flow
- Share repurchases
- Dividends
- Named executive commentary and executive quotes
- Tax rate
- Complete financial supplement pages after the truncated filing text, including the remainder of the Margin from Annuity Products table and subsequent sections
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
The SEC 8-K (Item 2.02) attaches a quarterly financial supplement for 2Q2026, with consolidated balance sheet, statement of operations, and financial summary tables.
Ticker impact
CNO filed an 8-K with its 2Q2026 results supplement, including consolidated balance sheet and income statement figures for 2026 quarters.
Likely modest, unless traders focus on a specific line item trend (investment losses, embedded derivative impacts, or margin changes) versus prior quarters.
The text includes detailed quarterly financial statement line items for 2025 and 2026, but it does not provide explicit guidance, deal terms, or a clear single surprise datapoint in the excerpt.
Market effects
Life insurers can see sentiment tied to investment income volatility and reserve-related items; this update may affect sector read-through modestly.
Primarily US-focused given the issuer and SEC filing.
Limited, unless investment portfolio moves signal broader credit or rates stress.
Counterpoint
Without explicit guidance or a clearly highlighted surprise metric in the excerpt, the market may treat this as routine quarterly disclosure rather than a catalyst.
Key entities
- public_companyCNO Financial Group, Inc.
US life insurer and filer of the 8-K with 2Q2026 results supplement.
